In Vivo Contract Research Organization (CRO) - Global Strategic Business Report (2026-2032) Featuring Strategic Intelligence on Charles River, ICON, Parexel and WuXi AppTec

Globenewswire_fr28 Oct 2026, 21:08 PKTvia NewsData.io

Outsourcing in vivo studies cuts costs and timelines, while AI, advanced imaging and genomics sharpen results. Toxicology and oncology lead, with emerging markets offering cost advantages.

Read the full story on Globenewswire_fr

Headline and summary provided via NewsData.io. The full article and its copyright belong to the original publisher.